| Salmeterol |
ІІ-16305 / 12.04.2007 г. |
Serevent inhaler, Pressurised inhalation, suspension, 25 mcg/dose x 120 doses, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline Pharmaceuticals SA, Poland; Glaxo Wellcome Production, France |
33.19 |
6.64 |
39.83 |
4% |
1.33 |
34.52 |
6.9 |
41.42 |
16% |
5.31 |
39.83 |
7.97 |
47.8 |
|
КЦ-704/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3433 |
| Nicergoline |
20030546 |
SERMION, Film coated tablet, 10, mg, Pack: 90 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l.,Italy |
17.62 |
3.52 |
21.14 |
6% |
1.06 |
18.68 |
3.74 |
22.42 |
18% |
3.17 |
21.85 |
4.37 |
26.22 |
Отхвърлена жалба от Комисия по прозрачност КП-88/24.09.2014; Промяна на обстоятелствата НСР-15420/04.04.2018; НСР-17196/09.11.2018; Корекционно решение НСР-17535/13.12.2018 |
НСР-1158/13.09.2013 |
16.10.2014 |
02.01.2019 |
Активен |
3212 |
| Nicergoline |
20030546 |
SERMION, Film coated tablet, 10, mg, Pack: 90 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l.,Italy |
17.62 |
3.52 |
21.14 |
6% |
1.06 |
18.68 |
3.74 |
22.42 |
18% |
3.17 |
21.85 |
4.37 |
26.22 |
Отхвърлена жалба от Комисия по прозрачност КП-88/24.09.2014; Промяна на обстоятелствата НСР-15420/04.04.2018; НСР-17196/09.11.2018 |
НСР-1158/13.09.2013 |
16.10.2014 |
02.12.2018 |
Неактивен |
3212 |
| Nicergoline |
20030546 |
SERMION, Film coated tablet, 10, mg, Pack: 90 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
17.62 |
3.52 |
21.14 |
6% |
1.06 |
18.68 |
3.74 |
22.42 |
18% |
3.17 |
21.85 |
4.37 |
26.22 |
Отхвърлена жалба от Комисия по прозрачност КП-88/24.09.2014; Промяна на обстоятелствата НСР-15420/04.04.2018 |
НСР-1158/13.09.2013 |
16.10.2014 |
02.05.2018 |
Неактивен |
3212 |
| Nicergoline |
9179/26.03.2010 |
SERMION, Film coated tablet, 10, mg, Pack: 90 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
17.62 |
3.52 |
21.14 |
6% |
1.06 |
18.68 |
3.74 |
22.42 |
18% |
3.17 |
21.85 |
4.37 |
26.22 |
Отхвърлена жалба от Комисия по прозрачност КП-88/24.09.2014 |
НСР-1158/13.09.2013 |
16.10.2014 |
16.10.2014 |
Неактивен |
3212 |
| Nicergoline |
9179/26.03.2010 |
SERMION, Film coated tablet, 10, mg, Pack: 90 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
17.62 |
3.52 |
21.14 |
6% |
1.06 |
18.68 |
3.74 |
22.42 |
18% |
3.17 |
21.85 |
4.37 |
26.22 |
Отхвърлена жалба от Комисия по прозрачност КП-88/24.09.2014 |
НСР-1158/13.09.2013 |
16.10.2014 |
16.10.2014 |
Неактивен |
3212 |
| Nicergoline |
9179/26.03.2010 |
SERMION, Film coated tablet, 10, mg, Pack: 90 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
19.01 |
3.8 |
22.81 |
6% |
1.14 |
20.15 |
4.03 |
24.18 |
18% |
3.42 |
23.57 |
4.71 |
28.28 |
|
КЦ-1653/21.06.2010 |
19.07.2010 |
19.07.2010 |
Неактивен |
3212 |
| Nicergoline |
II-4084/29.01.2009 |
SERMION, Coated tablet, 10, mg, Pack: 50 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
9.8 |
1.96 |
11.76 |
7% |
0.69 |
10.49 |
2.1 |
12.59 |
20% |
1.96 |
12.45 |
2.49 |
14.94 |
Цената се заличава с решение НСР-3711/06.06.2014 ( в сила от 23.06.2014) |
НСР-3599/23.05.2014 |
06.06.2014 |
06.06.2014 |
Заличен |
2829 |
| Nicergoline |
II-4084/29.01.2009 |
SERMION, Coated tablet, 10, mg, Pack: 50 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
10.56 |
2.11 |
12.67 |
6% |
0.63 |
11.19 |
2.24 |
13.43 |
18% |
1.9 |
13.09 |
2.62 |
15.71 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2829 |
| Nicergoline |
II-4083/29.01.2009 |
SERMION, Powder and solvent for solution for injection, 4, mg, Pack: 4 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
5.57 |
1.11 |
6.68 |
7% |
0.39 |
5.96 |
1.19 |
7.15 |
20% |
1.11 |
7.07 |
1.41 |
8.48 |
Цената се заличава с решение НСР-3485/16.05.2014 |
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Заличен |
617 |
| Nicergoline |
20030546 |
SERMION, Film coated tablet, 10, mg, Pack: 30 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l.,Italy |
6.34 |
1.27 |
7.61 |
7% |
0.44 |
6.78 |
1.36 |
8.14 |
20% |
1.27 |
8.05 |
1.61 |
9.66 |
Промяна на обстоятелствата НСР-15419/04.04.2018; НСР-17196/09.11.2018; Корекционно решение НСР-17535/13.12.2018 |
КЦ-1653/21.06.2010 |
19.07.2010 |
02.01.2019 |
Активен |
952 |
| Nicergoline |
20030546 |
SERMION, Film coated tablet, 10, mg, Pack: 30 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l.,Italy |
6.34 |
1.27 |
7.61 |
7% |
0.44 |
6.78 |
1.36 |
8.14 |
20% |
1.27 |
8.05 |
1.61 |
9.66 |
Промяна на обстоятелствата НСР-15419/04.04.2018; НСР-17196/09.11.2018 |
КЦ-1653/21.06.2010 |
19.07.2010 |
02.12.2018 |
Неактивен |
952 |
| Nicergoline |
20030547 |
SERMION, Film coated tablet, 30, mg, Pack: 30 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Italy |
14.28 |
2.86 |
17.14 |
6% |
0.86 |
15.14 |
3.03 |
18.17 |
18% |
2.57 |
17.71 |
3.54 |
21.25 |
промяна в обстоятелствата НСР-7832/15.01.2016; НСР-17196/09.11.2018; Корекционно решение НСР-17535/13.12.2018 |
НСР-7478/12.11.2015; НСР-10347/26.09.2016 |
11.10.2016 |
02.01.2019 |
Активен |
2012 |
| Nicergoline |
20030547 |
SERMION, Film coated tablet, 30, mg, Pack: 30 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Italy |
14.28 |
2.86 |
17.14 |
6% |
0.86 |
15.14 |
3.03 |
18.17 |
18% |
2.57 |
17.71 |
3.54 |
21.25 |
промяна в обстоятелствата НСР-7832/15.01.2016; НСР-17196/09.11.2018 |
НСР-7478/12.11.2015; НСР-10347/26.09.2016 |
11.10.2016 |
02.12.2018 |
Неактивен |
2012 |
| Nicergoline |
20030547 |
SERMION, Film coated tablet, 30, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Italy |
14.28 |
2.86 |
17.14 |
6% |
0.86 |
15.14 |
3.03 |
18.17 |
18% |
2.57 |
17.71 |
3.54 |
21.25 |
промяна в обстоятелствата НСР-7832/15.01.2016. |
НСР-7478/12.11.2015; НСР-10347/26.09.2016 |
11.10.2016 |
02.11.2016 |
Неактивен |
2012 |
| Nicergoline |
20030546 |
SERMION, Film coated tablet, 10, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
6.34 |
1.27 |
7.61 |
7% |
0.44 |
6.78 |
1.36 |
8.14 |
20% |
1.27 |
8.05 |
1.61 |
9.66 |
Промяна на обстоятелствата НСР-15419/04.04.2018 |
КЦ-1653/21.06.2010 |
19.07.2010 |
02.05.2018 |
Неактивен |
952 |
| Nicergoline |
9179/26.03.2010 |
SERMION, Film coated tablet, 10, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
6.34 |
1.27 |
7.61 |
7% |
0.44 |
6.78 |
1.36 |
8.14 |
20% |
1.27 |
8.05 |
1.61 |
9.66 |
|
КЦ-1653/21.06.2010 |
19.07.2010 |
19.07.2010 |
Неактивен |
952 |
| Nicergoline |
9179/26.03.2010 |
SERMION, Film coated tablet, 10, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l.,Italy |
6.34 |
1.27 |
7.61 |
7% |
0.44 |
6.78 |
1.36 |
8.14 |
20% |
1.27 |
8.05 |
1.61 |
9.66 |
|
КЦ-1653/21.06.2010 |
19.07.2010 |
19.07.2010 |
Неактивен |
952 |
| Nicergoline |
20030547 |
SERMION, Film coated tablet, 30, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Italy |
14.34 |
2.87 |
17.21 |
6% |
0.86 |
15.2 |
3.04 |
18.24 |
18% |
2.58 |
17.78 |
3.56 |
21.34 |
промяна в обстоятелствата НСР-7832/15.01.2016. |
НСР-7478/12.11.2015 |
27.11.2015 |
27.11.2015 |
Неактивен |
2012 |
| Nicergoline |
1124/03.12.2007 г. |
SERMION, Film coated tablet, 30, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Italy |
14.88 |
2.98 |
17.86 |
6% |
0.89 |
15.77 |
3.15 |
18.92 |
18% |
2.68 |
18.45 |
3.69 |
22.14 |
|
НСР-620/23.07.2013 |
20.08.2013 |
20.08.2013 |
Неактивен |
2012 |
| Nicergoline |
1124/03.12.2007 г. |
SERMION, Film coated tablet, 30, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Italy |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
издадена корекционна КЦ-864/12.05.2009 |
КЦ-857/12.05.2009 |
29.05.2009 |
29.05.2009 |
Неактивен |
2012 |
| Quetiapine |
II-1025/ 16.11.2007 |
Seroquel XR, Prolonged release tablet, 300, mg, Pack: 60 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca AB, Sweden; AstraZeneca UK Ltd, UK; AstraZeneca GmbH, Germany; AstraZeneca GmbH, Germany; NV AstraZeneca SA, Belgium; AtraZeneca Farmaceutica Spain S.A., Spain |
264.41 |
52.88 |
317.29 |
4% |
10 |
274.41 |
54.88 |
329.29 |
16% |
25 |
299.41 |
59.88 |
359.29 |
цената е заличена с решение КЦРР-2136/28.01.2013 |
КЦ-409/07.01.2009 |
02.02.2009 |
02.02.2009 |
Заличен |
442 |
| Quetiapine |
II-1027/ 16.11.2007 |
Seroquel XR, Prolonged release tablet, 50, mg, Pack: 60 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca AB, Sweden; AstraZeneca UK Ltd, UK; AstraZeneca GmbH, Germany; AstraZeneca GmbH, Germany; NV AstraZeneca SA, Belgium; AtraZeneca Farmaceutica Spain S.A., Spain |
85.88 |
17.18 |
103.06 |
4% |
3.44 |
89.32 |
17.86 |
107.18 |
16% |
13.74 |
103.06 |
20.61 |
123.67 |
цената е заличена с решение КЦРР-2136/28.01.2013 |
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Заличен |
412 |
| Quetiapine |
II-1026/ 16.11.2007 |
Seroquel XR, Prolonged release tablet, 400, mg, Pack: 60 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca AB, Sweden; AstraZeneca UK Ltd, UK; AstraZeneca GmbH, Germany; AstraZeneca GmbH, Germany; NV AstraZeneca SA, Belgium; AtraZeneca Farmaceutica Spain S.A., Spain |
357.47 |
71.49 |
428.96 |
4% |
10 |
367.47 |
73.49 |
440.96 |
16% |
25 |
392.47 |
78.49 |
470.96 |
цената е заличена с решение КЦРР-1362/05.09.2012 |
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Заличен |
411 |
| Quetiapine |
II-1024/ 16.11.2007 |
Seroquel XR, Prolonged release tablet, 200, mg, Pack: 60 |
AstraZeneca Pharmaceuticals AB, Швеция |
AstraZeneca AB, Sweden; AstraZeneca UK Ltd, UK; AstraZeneca GmbH, Germany; AstraZeneca GmbH, Germany; NV AstraZeneca SA, Belgium; AtraZeneca Farmaceutica Spain S.A., Spain |
178.7 |
35.74 |
214.44 |
4% |
7.15 |
185.85 |
37.17 |
223.02 |
16% |
25 |
210.85 |
42.17 |
253.02 |
цената е заличена с решение КЦРР-2136/28.01.2013 |
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Заличен |
410 |